CliffBio
small molecule

SOAANZ

TORSEMIDE

Loss of exclusivityOctober 2033latest FDA-listed patent expiry
CompanySarfez Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameSOAANZ
Active ingredientTORSEMIDE
Strength60MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 2021
Marketing statusDISCN

Listed patents

PatentExpiresType
10154963October 2033product

More from Sarfez Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SOAANZ patent cliff — loss of exclusivity October 2033 | CliffBio